The protein polymorphism of the growth hormone receptor characterized by the genomic deletion
of exon 3 has been linked to the magnitude of the first-year-growth response to growth
hormone (GH) in girls with Turner syndrome.
Objective: to study the long-term effect of GH therapy in Turner syndrome in correlation to
this GHR polymorphism in a mainly retrospective design (chart-review).